# Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease

Study · id `cardio:ct-nct07359027` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07359027](<https://clinicaltrials.gov/study/NCT07359027>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07359027

Browse, organ or system: Kidneys; Metabolism  
Browse, condition area: Diabetes and metabolic disease; Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.

## Technical summary

Registry record NCT07359027. Allocation not applicable; no masking; primary purpose treatment. Start 2021-11-02 (actual); primary completion 2022-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 124 participants (enrolled count; ClinicalTrials.gov record NCT07359027, source copy `cardio:ctgov-nct07359027-2026-01-26`, retrieved 2026-10-26)
- Started: 2021-11-02 (actual) (ClinicalTrials.gov record NCT07359027, source copy `cardio:ctgov-nct07359027-2026-01-26`, retrieved 2026-10-26)
- Primary completion: 2022-12-31 (actual) (ClinicalTrials.gov record NCT07359027, source copy `cardio:ctgov-nct07359027-2026-01-26`, retrieved 2026-10-26)
- Completion: 2024-07-08 (actual) (ClinicalTrials.gov record NCT07359027, source copy `cardio:ctgov-nct07359027-2026-01-26`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07359027, source copy `cardio:ctgov-nct07359027-2026-01-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07359027-2026-01-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease
- Condition: Diabetic Kidney Disease
- Condition: Anemia
- Intervention (Drug): Roxadustat
- Lead sponsor: Second Xiangya Hospital of Central South University
- Lead sponsor class: OTHER
- Collaborator: Xiangya Hospital of Central South University
- Collaborator class: OTHER
- Collaborator: The Third Xiangya Hospital of Central South University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetic kidney disease (`cardio:diabetic-nephropathy`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Second Xiangya Hospital of Central South University (`cardio:org-second-xiangya-hospital-of-central-south-university`)
- Registry lists this organization as a collaborator: Xiangya Hospital of Central South University (`cardio:org-xiangya-hospital-of-central-south-university`)
- Registry lists this organization as a collaborator: The Third Xiangya Hospital of Central South University (`cardio:org-the-third-xiangya-hospital-of-central-south-university`)

## Provenance

Content hash: 624b1be1e6e13e7d1d862dc6dee5e00d8d70966abb64448d15191c217898579e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
